# IZERVAY
> **NDA217225** · New Drug Application · Sponsor: ASTELLAS · Approved 2023-08-04
## Drug
- **FDA Application Number:** NDA217225
- **Application type:** New Drug Application
- **Brand name:** IZERVAY
- **Generic name:** AVACINCAPTAD PEGOL
- **Active ingredients:** AVACINCAPTAD PEGOL SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVITREAL
- **Marketing status:** Prescription
- **Sponsor:** ASTELLAS
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2023-08-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217225)
---
*MORVS · CC0 1.0*